Global Schizochytrium Powder Market Growth 2025-2031

Publication ID:

LPI06251028

Publication Date:

June 27, 2025

Pages:

108

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Organic Farming [2]

Agriculture [3]

Industry & Manufacturing [4]

Description:

The global Schizochytrium Powder market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Schizochytrium Powder is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Schizochytrium Powder is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Schizochytrium Powder is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Schizochytrium Powder players cover ATK Biotech, Vita Actives, ALGANEX, HUISON, DHA Algal Oil, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淪chizochytrium Powder Industry Forecast鈥� looks at past sales and reviews total world Schizochytrium Powder sales in 2024, providing a comprehensive analysis by region and market sector of projected Schizochytrium Powder sales for 2025 through 2031. With Schizochytrium Powder sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Schizochytrium Powder industry.
This Insight Report provides a comprehensive analysis of the global Schizochytrium Powder landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Schizochytrium Powder portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Schizochytrium Powder market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Schizochytrium Powder and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Schizochytrium Powder.
This report presents a comprehensive overview, market shares, and growth opportunities of Schizochytrium Powder market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
0.18
0.22
Other
Segmentation by Application:
Aquafeed
Livestock Feed
Pet Health Products
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
ATK Biotech
Vita Actives
ALGANEX
HUISON
DHA Algal Oil
Touchhealthy
IMAHERB BIOTECH
Shandong Nautical Biotechnology
Shandong Yuexiang Biotechnology
Shandong Binzhou Tianjian Biotechnology
Hubei Xinhe Biotechnology
Xiamen Huisheng Biotechnology
Qingdao Langyatai Group
Capiyou Biotechnology (Wuhan)
Anhui Tiankai Biotechnology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Schizochytrium Powder market?
What factors are driving Schizochytrium Powder market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Schizochytrium Powder market opportunities vary by end market size?
How does Schizochytrium Powder break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Schizochytrium Powder Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Schizochytrium Powder by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Schizochytrium Powder by Country/Region, 2020, 2024 & 2031
2.2 Schizochytrium Powder Segment by Type
2.2.1 0.18
2.2.2 0.22
2.2.3 Other
2.3 Schizochytrium Powder Sales by Type
2.3.1 Global Schizochytrium Powder Sales Market Share by Type (2020-2025)
2.3.2 Global Schizochytrium Powder Revenue and Market Share by Type (2020-2025)
2.3.3 Global Schizochytrium Powder Sale Price by Type (2020-2025)
2.4 Schizochytrium Powder Segment by Application
2.4.1 Aquafeed
2.4.2 Livestock Feed
2.4.3 Pet Health Products
2.4.4 Other
2.5 Schizochytrium Powder Sales by Application
2.5.1 Global Schizochytrium Powder Sale Market Share by Application (2020-2025)
2.5.2 Global Schizochytrium Powder Revenue and Market Share by Application (2020-2025)
2.5.3 Global Schizochytrium Powder Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Schizochytrium Powder Breakdown Data by Company
3.1.1 Global Schizochytrium Powder Annual Sales by Company (2020-2025)
3.1.2 Global Schizochytrium Powder Sales Market Share by Company (2020-2025)
3.2 Global Schizochytrium Powder Annual Revenue by Company (2020-2025)
3.2.1 Global Schizochytrium Powder Revenue by Company (2020-2025)
3.2.2 Global Schizochytrium Powder Revenue Market Share by Company (2020-2025)
3.3 Global Schizochytrium Powder Sale Price by Company
3.4 Key Manufacturers Schizochytrium Powder Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Schizochytrium Powder Product Location Distribution
3.4.2 Players Schizochytrium Powder Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Schizochytrium Powder by Geographic Region
4.1 World Historic Schizochytrium Powder Market Size by Geographic Region (2020-2025)
4.1.1 Global Schizochytrium Powder Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Schizochytrium Powder Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Schizochytrium Powder Market Size by Country/Region (2020-2025)
4.2.1 Global Schizochytrium Powder Annual Sales by Country/Region (2020-2025)
4.2.2 Global Schizochytrium Powder Annual Revenue by Country/Region (2020-2025)
4.3 Americas Schizochytrium Powder Sales Growth
4.4 APAC Schizochytrium Powder Sales Growth
4.5 Europe Schizochytrium Powder Sales Growth
4.6 Middle East & Africa Schizochytrium Powder Sales Growth
5 Americas
5.1 Americas Schizochytrium Powder Sales by Country
5.1.1 Americas Schizochytrium Powder Sales by Country (2020-2025)
5.1.2 Americas Schizochytrium Powder Revenue by Country (2020-2025)
5.2 Americas Schizochytrium Powder Sales by Type (2020-2025)
5.3 Americas Schizochytrium Powder Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Schizochytrium Powder Sales by Region
6.1.1 APAC Schizochytrium Powder Sales by Region (2020-2025)
6.1.2 APAC Schizochytrium Powder Revenue by Region (2020-2025)
6.2 APAC Schizochytrium Powder Sales by Type (2020-2025)
6.3 APAC Schizochytrium Powder Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Schizochytrium Powder by Country
7.1.1 Europe Schizochytrium Powder Sales by Country (2020-2025)
7.1.2 Europe Schizochytrium Powder Revenue by Country (2020-2025)
7.2 Europe Schizochytrium Powder Sales by Type (2020-2025)
7.3 Europe Schizochytrium Powder Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Schizochytrium Powder by Country
8.1.1 Middle East & Africa Schizochytrium Powder Sales by Country (2020-2025)
8.1.2 Middle East & Africa Schizochytrium Powder Revenue by Country (2020-2025)
8.2 Middle East & Africa Schizochytrium Powder Sales by Type (2020-2025)
8.3 Middle East & Africa Schizochytrium Powder Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Schizochytrium Powder
10.3 Manufacturing Process Analysis of Schizochytrium Powder
10.4 Industry Chain Structure of Schizochytrium Powder
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Schizochytrium Powder Distributors
11.3 Schizochytrium Powder Customer
12 World Forecast Review for Schizochytrium Powder by Geographic Region
12.1 Global Schizochytrium Powder Market Size Forecast by Region
12.1.1 Global Schizochytrium Powder Forecast by Region (2026-2031)
12.1.2 Global Schizochytrium Powder Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Schizochytrium Powder Forecast by Type (2026-2031)
12.7 Global Schizochytrium Powder Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 ATK Biotech
13.1.1 ATK Biotech Company Information
13.1.2 ATK Biotech Schizochytrium Powder Product Portfolios and Specifications
13.1.3 ATK Biotech Schizochytrium Powder Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 ATK Biotech Main Business Overview
13.1.5 ATK Biotech Latest Developments
13.2 Vita Actives
13.2.1 Vita Actives Company Information
13.2.2 Vita Actives Schizochytrium Powder Product Portfolios and Specifications
13.2.3 Vita Actives Schizochytrium Powder Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Vita Actives Main Business Overview
13.2.5 Vita Actives Latest Developments
13.3 ALGANEX
13.3.1 ALGANEX Company Information
13.3.2 ALGANEX Schizochytrium Powder Product Portfolios and Specifications
13.3.3 ALGANEX Schizochytrium Powder Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 ALGANEX Main Business Overview
13.3.5 ALGANEX Latest Developments
13.4 HUISON
13.4.1 HUISON Company Information
13.4.2 HUISON Schizochytrium Powder Product Portfolios and Specifications
13.4.3 HUISON Schizochytrium Powder Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 HUISON Main Business Overview
13.4.5 HUISON Latest Developments
13.5 DHA Algal Oil
13.5.1 DHA Algal Oil Company Information
13.5.2 DHA Algal Oil Schizochytrium Powder Product Portfolios and Specifications
13.5.3 DHA Algal Oil Schizochytrium Powder Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 DHA Algal Oil Main Business Overview
13.5.5 DHA Algal Oil Latest Developments
13.6 Touchhealthy
13.6.1 Touchhealthy Company Information
13.6.2 Touchhealthy Schizochytrium Powder Product Portfolios and Specifications
13.6.3 Touchhealthy Schizochytrium Powder Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Touchhealthy Main Business Overview
13.6.5 Touchhealthy Latest Developments
13.7 IMAHERB BIOTECH
13.7.1 IMAHERB BIOTECH Company Information
13.7.2 IMAHERB BIOTECH Schizochytrium Powder Product Portfolios and Specifications
13.7.3 IMAHERB BIOTECH Schizochytrium Powder Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 IMAHERB BIOTECH Main Business Overview
13.7.5 IMAHERB BIOTECH Latest Developments
13.8 Shandong Nautical Biotechnology
13.8.1 Shandong Nautical Biotechnology Company Information
13.8.2 Shandong Nautical Biotechnology Schizochytrium Powder Product Portfolios and Specifications
13.8.3 Shandong Nautical Biotechnology Schizochytrium Powder Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Shandong Nautical Biotechnology Main Business Overview
13.8.5 Shandong Nautical Biotechnology Latest Developments
13.9 Shandong Yuexiang Biotechnology
13.9.1 Shandong Yuexiang Biotechnology Company Information
13.9.2 Shandong Yuexiang Biotechnology Schizochytrium Powder Product Portfolios and Specifications
13.9.3 Shandong Yuexiang Biotechnology Schizochytrium Powder Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Shandong Yuexiang Biotechnology Main Business Overview
13.9.5 Shandong Yuexiang Biotechnology Latest Developments
13.10 Shandong Binzhou Tianjian Biotechnology
13.10.1 Shandong Binzhou Tianjian Biotechnology Company Information
13.10.2 Shandong Binzhou Tianjian Biotechnology Schizochytrium Powder Product Portfolios and Specifications
13.10.3 Shandong Binzhou Tianjian Biotechnology Schizochytrium Powder Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Shandong Binzhou Tianjian Biotechnology Main Business Overview
13.10.5 Shandong Binzhou Tianjian Biotechnology Latest Developments
13.11 Hubei Xinhe Biotechnology
13.11.1 Hubei Xinhe Biotechnology Company Information
13.11.2 Hubei Xinhe Biotechnology Schizochytrium Powder Product Portfolios and Specifications
13.11.3 Hubei Xinhe Biotechnology Schizochytrium Powder Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Hubei Xinhe Biotechnology Main Business Overview
13.11.5 Hubei Xinhe Biotechnology Latest Developments
13.12 Xiamen Huisheng Biotechnology
13.12.1 Xiamen Huisheng Biotechnology Company Information
13.12.2 Xiamen Huisheng Biotechnology Schizochytrium Powder Product Portfolios and Specifications
13.12.3 Xiamen Huisheng Biotechnology Schizochytrium Powder Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Xiamen Huisheng Biotechnology Main Business Overview
13.12.5 Xiamen Huisheng Biotechnology Latest Developments
13.13 Qingdao Langyatai Group
13.13.1 Qingdao Langyatai Group Company Information
13.13.2 Qingdao Langyatai Group Schizochytrium Powder Product Portfolios and Specifications
13.13.3 Qingdao Langyatai Group Schizochytrium Powder Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Qingdao Langyatai Group Main Business Overview
13.13.5 Qingdao Langyatai Group Latest Developments
13.14 Capiyou Biotechnology (Wuhan)
13.14.1 Capiyou Biotechnology (Wuhan) Company Information
13.14.2 Capiyou Biotechnology (Wuhan) Schizochytrium Powder Product Portfolios and Specifications
13.14.3 Capiyou Biotechnology (Wuhan) Schizochytrium Powder Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Capiyou Biotechnology (Wuhan) Main Business Overview
13.14.5 Capiyou Biotechnology (Wuhan) Latest Developments
13.15 Anhui Tiankai Biotechnology
13.15.1 Anhui Tiankai Biotechnology Company Information
13.15.2 Anhui Tiankai Biotechnology Schizochytrium Powder Product Portfolios and Specifications
13.15.3 Anhui Tiankai Biotechnology Schizochytrium Powder Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Anhui Tiankai Biotechnology Main Business Overview
13.15.5 Anhui Tiankai Biotechnology Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂